🔎 Trials Near Me

Home › COPD › Florida › Miami

COPD clinical trials in Miami, FL

18 studies for COPD are looking for participants at sites in and around Miami (within about 30 miles). Open a study to see who can join and how to contact the study team.

A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)

RecruitingPhase 3
  • GSK Investigational Site, Miami
Ages 40 to 80 · All sexes · Updated Sep 25, 2026 · NCT07780656

A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

RecruitingPhase 2
  • Millennium Medical Research - Miami, Miami
Ages 40 to 75 · All sexes · Updated Sep 25, 2026 · NCT07759245

A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.

RecruitingPhase 4
  • University of Miami Dermatology Clinical Trials Unit- Site Number : 8400015, Miami
  • Finlay Medical Research- Site Number : 8400010, Miami
Ages 40 to 85 · All sexes · Updated Sep 22, 2026 · NCT07053423

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

RecruitingPhase 3
  • University of Miami Dermatology Clinical Trials Unit- Site Number : 8400078, Miami
  • MCR Research- Site Number : 8400004, Miami
  • Nuren Medical & Research Center- Site Number : 8400030, Miami
  • and 1 more
Ages 40 to 80 · All sexes · Updated Sep 22, 2026 · NCT07190209

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

RecruitingPhase 3
  • DL Research Solutions- Site Number : 8400140, Miami
  • Phoenix Medical Research - Miami - 24th Street- Site Number : 8400027, Miami
  • Professional Research Center- Site Number : 8400046, Miami
  • and 2 more
Ages 40 to 80 · All sexes · Updated Sep 15, 2026 · NCT07190222

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

RecruitingPhase 2
  • Research Site, Miami
  • Research Site, Miami
  • Research Site, Miami
  • and 2 more
Ages 40 and older · All sexes · Updated Sep 9, 2026 · NCT07082738

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

RecruitingPhase 3
  • Research Site, Miami
Ages 40 to 80 · All sexes · Updated Sep 3, 2026 · NCT06878261

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

RecruitingPhase 3
  • Research Site, Miami
  • Research Site, Miami
  • Research Site, Miami
Ages 40 to 80 · All sexes · Updated Sep 3, 2026 · NCT06883305

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

RecruitingPhase 2/3
  • Reed Medical Research, Miami
Ages 35 to 80 · All sexes · Updated Aug 31, 2026 · NCT07363694

Rademikibart IV for Acute Asthma and COPD Exacerbation

RecruitingPhase 2
  • Columbus Clinical Services, LLC, Miami
  • Pharmax Research of South Florida, Inc., Miami
Ages 18 to 85 · All sexes · Updated Aug 27, 2026 · NCT07705737

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

RecruitingPhase 3
  • Research Site, Miami
  • Research Site, Miami
Ages 40 to 80 · All sexes · Updated Aug 26, 2026 · NCT06283966

To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment

RecruitingPhase 2
  • Suncoast Research Group, LLC Miami - Little Havana dba Flourish Research, Miami
Ages 40 to 85 · All sexes · Updated Aug 7, 2026 · NCT07684820

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

RecruitingPhase 3
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
Ages 40 to 75 · All sexes · Updated Jul 28, 2026 · NCT07177339

Physiologic Effects of Nasal High Flow on Exercise Tolerance in COPD

Recruiting
  • University of Miami, Miami
Ages 18 to 100 · All sexes · Updated Jun 22, 2026 · NCT06578156

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

RecruitingPhase 3
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
  • and 4 more
Ages 40 to 80 · All sexes · Updated Apr 9, 2026 · NCT06961214

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)

RecruitingPhase 3
  • GSK Investigational Site, Miami
Ages 40 to 80 · All sexes · Updated Oct 8, 2025 · NCT06959095

myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

Recruiting
  • Reliable Research, Inc., Miami
  • NewGen Health Group, Miami
Ages 30 and older · All sexes · Updated Feb 6, 2025 · NCT05204888

About COPD

COPD (chronic obstructive pulmonary disease) makes it hard for you to breathe. At first symptoms are mild, but they usually become more severe. Learn more.

More about COPD on MedlinePlus

COPD trials in other cities

Other studies in Miami

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.